ASP Isotopes Inc. (NASDAQ: ASPI) announced today that its subsidiary, Quantum Leap Energy LLC (QLE), has entered into a non-binding memorandum of understanding (MOU) with a large U.S. energy company operating nuclear power stations. The MOU outlines the evaluation of support for QLE's plans to establish advanced nuclear fuel cycle facilities in the United States.
The facilities are planned to produce high assay low enriched uranium (HALEU) and low enriched uranium plus (LEU+), as well as provide uranium conversion and deconversion services. QLE believes these fuels are vital for the United States, with many advanced nuclear reactors, including small modular reactors, expected to rely on HALEU. Additionally, QLE aims to make LEU+ available to the existing fleet of nuclear reactors, enabling them to lengthen the time between refueling, cut costs, and boost power output.
Ryno Pretorius, CEO of Quantum Leap Energy, highlighted the significance of the MOU, stating that it represents an important step in QLE's efforts to help establish a domestic supply chain for advanced nuclear fuels. The company aims to advance technical diligence and evaluate potential pathways toward long-term commercial collaboration.
This development comes at a time of growing urgency to increase U.S.-based uranium enrichment capacity, particularly HALEU production capabilities. With the federal government's ban on Russian uranium imports starting in 2028 and increasing demand from next-generation reactor developers, domestic suppliers are expected to fill a critical perceived gap in the nuclear fuel supply chain.
Quantum Leap Energy is a development stage nuclear fuels company focused on advancing innovative technologies and processes across critical segments of the nuclear fuel cycle. The company has global rights to proprietary aerodynamic separation process (ASP) and laser-based quantum enrichment (QE) technologies, aiming to address perceived gaps in the nuclear fuel supply chain for advanced nuclear reactors, small modular reactors, and fusion systems.
ASP Isotopes Inc. is a development stage advanced materials company building a differentiated isotope enrichment platform to enhance global supply chain access to critical materials for nuclear medicine, next-generation semiconductors, and nuclear energy. The company is focused on producing and commercializing highly enriched isotopes for the healthcare and technology industries and plans to enrich isotopes for the nuclear energy sector using QE technology. As a result of these announcements, the company's shares have moved 3.48% on the market, and are now trading at a price of $7.74. For more information, read the company's full 8-K submission here.
